Gene · 10411
Papers2,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated network toxicology and computational profiling of acetyl tributyl citrate-related mechanisms in Alzheimer's disease. | J Alzheimers Dis | 2026 | 41823681 | PubTator, text mining | PubMed |
Retraction notice to "The cAMP-activated GTP exchange factor, Epac1 upregulates plasma membrane and nuclear Akt kinase activities in 8-CPT-2-O-Me-cAMP-stimulated macrophages: Gene silencing of the cAMP-activated GTP exchange Epac1 prevents 8-CPT-2-O-Me-cAMP activation of Akt activity in macrophages" [Cellular Signalling 20 (2008) 1459-1470]. | Cell Signal | 2026 | 41807159 | PubTator, text mining | PubMed |
| APC-targeted DNA vaccines: the role of CCL19 in immune cell recruitment and early onset of the immune response. | Cancer Immunol Immunother | 2026 | 41806188 | PubTator, text mining | PubMed |
| Regulatory roles of bioactive lipids in vascular homeostasis and remodeling. | Med Rev (2021) | 2026 | 41783891 | PubTator, text mining | PubMed |
| Targeting molecular pathways in neuropathic cancer pain: from mechanisms to novel therapeutics. | iScience | 2026 | 41782818 | PubTator, text mining | PubMed |
| Epigenetic regulation in type II diabetes: linking molecular mechanisms to clinical management. | J Diabetes Metab Disord | 2026 | 41767434 | PubTator, text mining | PubMed |
| AZD4635 Targets cAMP/CREB Axis to Salvage PARPi-Induced Immune Evasion and Enhance Antitumor Efficacy in Ovarian Cancer. | Pharmaceutics | 2026 | 41754998 | PubTator, text mining | PubMed |
| Clinical Impact of Semaglutide Beyond Glycemic Control: A Critical Analysis of Oncogenic Potential and Mitigation of Cardiotoxicity. | Pharmaceuticals (Basel) | 2026 | 41754837 | PubTator, text mining | PubMed |
| An integrative ultrastructural and transcriptomic analysis of host-pathogen interactions with human brain microvascular endothelial cells during cryptococcal infection: a preliminary study. | Front Cell Infect Microbiol | 2026 | 41736794 | PubTator, text mining | PubMed |
| ESRP1 drives epithelial-mesenchymal transition by activating EPAC-RAP1A signaling axis. | Front Med (Lausanne) | 2026 | 41728622 | PubTator, text mining | PubMed |
| The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI. | Front Med (Lausanne) | 2026 | 41728592 | PubTator, text mining | PubMed |
| Antifibrotic Strategies Targeting Phosphodiesterase-4 in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms and Clinical Translation. | Clin Pharmacol | 2026 | 41726771 | PubTator, text mining | PubMed |
| Mechanistic basis for the antifibrotic actions of cAMP-based therapies. | Eur Respir Rev | 2026 | 41708123 | PubTator, text mining | PubMed |
| Single-cell analysis reveals neuroprotective histone deacetylase inhibitor pathways. | Alzheimers Dement | 2026 | 41630642 | PubTator, text mining | PubMed |
| Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgery. | J Immunother Cancer | 2026 | 41571294 | PubTator, text mining | PubMed |
| An artificial cell capable of signal transduction mediated by ADRB2 for the regulation of glycogenolysis. | Nat Commun | 2026 | 41545427 | PubTator, text mining | PubMed |
| Role of serine/threonine phosphatases 1 and 2A in pancreatic acinar fluid and electrolyte secretion. | Am J Physiol Gastrointest Liver Physiol | 2026 | 41525767 | PubTator, text mining | PubMed |
| Alterations of urinary proteomic profiles are correlated with return to sport after anterior cruciate ligament reconstruction. | BMC Sports Sci Med Rehabil | 2026 | 41519777 | PubTator, text mining | PubMed |
| cAMP-PKA/EPAC signaling pathways: crucial regulators of lipid homeostasis. | Adipocyte | 2026 | 41503874 | PubTator, text mining | PubMed |
| Protein Kinase Inhibitor Alpha Drives Vincristine Resistance in Ewing Sarcoma via cAMP-EPAC Signaling Reprogramming. | Mol Carcinog | 2026 | 41313792 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10411/papers?page=2